Vaughan Lennox Clift serves as Executive at Ampio Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Vaughan Lennox Clift has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 25, 2014 involved transacting 522,200 shares valued at $4.2M.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 25, 2014 | AMPE | $4.2M | Other | 522,200 | $8.02 | Discretionary |
Vaughan Lennox Clift currently holds 0 shares of Ampio Pharmaceuticals, Inc. (AMPE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vaughan Lennox Clift has been a net neutral trader of AMPE stock. They have purchased $0 and sold $0 worth of shares.
Vaughan Lennox Clift's most recent insider trade was on Feb 25, 2014, when they sold 522,200 shares at $8.02 per share.
Get notified when new Form 4 filings are submitted